VHA

Motus GI Reports First Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Wednesday, May 10, 2023
Workforce, Gastrointestinal disease, VHA, Small business, Quarter, Minneapolis, Motus, Veterans Health Administration, Endoscopy, Colon, Hospital, IBP, Diagnosis, Mortality, R, FDA, GI, MVA, Medical device, Pharmaceutical industry, Cryptocurrency

FORT LAUDERDALE, Fla., May 10, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, today reported its financial results for the first quarter ended March 31, 2023, and provided a corporate update.

Key Points: 
  • “We continue to advance the development of several potential growth drivers for our business, including R&D efforts to bring Pure-Vu Upper GI, and an enhanced Lower GI platform to market.
  • The planned 510(k) submission to the FDA for the Pure-Vu Gastro Upper GI system and advancements to the overall platform remains on track for the fourth quarter of 2023,” commented Mark Pomeranz, Chief Executive Officer.
  • Financial Results for the Quarter Ended March 31, 2023
    The Company reported revenue of $56,000 for the first quarter 2023, compared to $20,000 for the same period last year.
  • The Company reported $8.6 million in cash and cash equivalents as of March 31, 2023.

Molekule Signs Agreement to Provide Air Quality Monitoring Services to Veterans Affairs Facilities

Retrieved on: 
Thursday, May 4, 2023
PALM, VHA, Atmosphere, SARS-CoV-2, Organic compound, Influenza A virus subtype H1N1, IAQ, Woman, Volatile organic compound, Intelligence, Temperature, Veteran, POV, HVAC, Humidity, RSV, Visn, Veterans' affairs, Particulates, Health, FDA, Air quality index, Allergen, CO2, Safety, Real estate, Molekule

The mobilized solution allows the VA administration to access real-time IAQ data and receive alerts when IAQ levels exceed predetermined thresholds.

Key Points: 
  • The mobilized solution allows the VA administration to access real-time IAQ data and receive alerts when IAQ levels exceed predetermined thresholds.
  • The system gives VISN 23 operators recommendations for maintaining optimal air quality and evidence of the current state of IAQ.
  • Molekule implemented advanced IAQ monitoring technology and services in three VA service centers in Hot Springs, SD, Ft. Riley, KS, and Topeka, KS, and the solution has been running successfully for over a year.
  • The devices are part of a state-of-the-art advanced solutions platform, which includes IAQ monitoring and internet-of-things (“IoT”) device control.

Endonovo Launches SofPulse® into the Veterans Administration

Retrieved on: 
Tuesday, May 2, 2023
VHA, SDVOSB, IDN, Partnership, PEMF, Army, Traumatic brain injury, Veterans Health Administration, Edema, OTCQB, Federal, TBI, Veteran, CNS, Central nervous system, Military personnel, Healthcare Facilities Accreditation Program, Patient, Postal Index Number, Growth, FDA, Therapy, Pain, Health insurance, Pharmaceutical industry, Hospital

As was previously announced, Academy Medical will be reselling SofPulse® medical devices to the Veterans Health Administration (VHA) healthcare facilities, thereby ensuring its availability to the country’s military, veterans and their families.

Key Points: 
  • As was previously announced, Academy Medical will be reselling SofPulse® medical devices to the Veterans Health Administration (VHA) healthcare facilities, thereby ensuring its availability to the country’s military, veterans and their families.
  • This sales launch meeting marks the beginning of the partnership between Endonovo and Academy Medical.
  • With the launch of SofPulse® into the Federal marketplace Endonovo, along with Academy Medical, have the potential to significantly improve access to SofPulse® to military personnel and veterans.
  • “The partnership between Academy Medical and Endonovo provides veterans an opportunity to benefit from the device’s unique PEMF technology,” according to CEO, Tory Crawford, Army veteran.

U.S. Department of Veterans Affairs and The Rockefeller Foundation join forces to increase healthy food access, improve health outcomes for Veterans

Retrieved on: 
Monday, April 24, 2023
VHA, Partnership, Rockefeller Foundation, Prevalence, Diabetes, U.S. Department of Veterans Affairs, Office of Inspector General, Quality of life, Veterans Health Administration, Aircraft, AMVETS, Organization, Expanded Food and Nutrition Education Program, Risk, Produce, Overweight, Nutritionist, Food security, Pharmaceutical industry, Nursing, Veteran, Food, Medicine

WASHINGTON, April 24, 2023 /PRNewswire/ -- The U.S. Department of Veterans Affairs (VA) and The Rockefeller Foundation announced a new partnership to expand Food is Medicine programs, from medically tailored meals to produce prescription programs, at key VA health care facilities across the country.

Key Points: 
  • "We know good food is the foundation of good health, and study after study has found Food is Medicine interventions make people healthier even as they cut health care costs," said Dr. Rajiv J. Shah, President of The Rockefeller Foundation.
  • "I am proud the Foundation will be collaborating with the VA to help make American Veterans' lives healthier and more food secure.
  • VA is the largest integrated health care system in the United States providing care at more than 1,200 health care facilities to over nine million Veterans.
  • "Food is foundational for a healthy life, and it takes all of us — working together — to improve outcomes and nutrition for Veterans.

Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting

Retrieved on: 
Wednesday, April 12, 2023
Glycated hemoglobin, LSE, VHA, Disease, Medal "For Transforming the Non-Black Earth of the RSFSR", Kidney failure, Chronic kidney disease, Diabetes, Prevalence, Austin Convention Center, SGLT2 inhibitor, EGFR, Mount Sinai, Veteran, SALT, Icahn School of Medicine at Mount Sinai, Dialysis, Kidney, Patient, Division, Wake, NKF, Risk, National Kidney Foundation, UACR, DKD, CKD, T2D, Conference, Pharmaceutical industry, Black, Nephrology, Medicine

LONDON and SALT LAKE CITY, April 12, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced that two scientific presentations have been accepted at the upcoming National Kidney Foundation Spring Clinicals Conference taking place in Austin, Texas (April 11-15). The studies entitled the “Impact of KidneyIntelX testing on novel medication prescription in a diverse patient population” and “Diabetic kidney disease epidemiology in US veterans” show the importance of using KidneyIntelX bioprognosis in early stage kidney disease and diabetes patients to blunt the effects of health inequity, help guide proper drug prescription to patients in need, and support established clinical guidelines to slow or stop unnecessary progression to late stage kidney disease, kidney failure and dialysis.

Key Points: 
  • The webinar is now on-demand and available on www.kidneyintelx.com or via this link .
  • National Kidney Foundation Clinical Spring Conference Data Presentations Include:
    KidneyIntelX was recently introduced into the Wake Forest-Atrium Health System to predict progressive decline in kidney function.
  • The KidneyIntelX risk score identified those patients at highest risk which resulted in appropriately selecting SGLT2-inhibitors for the right patients.
  • The data will be showcased from April 12-14 in the Poster Hall at the Austin Convention Center and the abstract is now online at the NKF website.

InterSystems Technology Supports Quality Care for Veterans Nationwide

Retrieved on: 
Wednesday, April 12, 2023
Data Management, Technology, Managed Care, White House, Federal Government, Health, General Health, Veterans, Other Technology, Software, Defense, Public Policy, Government, VHA, Public, API management, JavaScript, Nursing care plan, Python, API, Catalog, Veterans Health Administration, FHIR, Veteran, United States Department of Veterans Affairs, CDC, Food and Drug Administration Amendments Act of 2007, AIRA, Knowledge, FDA, Veterans' affairs, VistA, Information technology architecture, COVID-19, CCDA, Consolidated Clinical Document Architecture, CCRA, Kenya Army Infantry, InterSystems, Senior Executive Service (United States), Ruby, Partnership, Information technology, Centers for Disease Control and Prevention, IIS, Infantry Branch (United States), Immunization, Roger Hawkins (drummer), Food, Hospital, Real estate, Vaccine, Nursing, HIMSS

InterSystems , a creative data technology provider dedicated to helping customers solve the most critical scalability, interoperability, and speed problems, today announced it is showcasing Department of Veterans Affairs (VA) programs at the HIMSS annual conference that deliver quality care to veterans nationwide.

Key Points: 
  • InterSystems , a creative data technology provider dedicated to helping customers solve the most critical scalability, interoperability, and speed problems, today announced it is showcasing Department of Veterans Affairs (VA) programs at the HIMSS annual conference that deliver quality care to veterans nationwide.
  • Their solutions help providers obtain a full picture of a patient’s health history and enable veterans’ access to critical care.
  • While there are many VA integration partners using the InterSystems license, two VA initiatives will be presented at HIMSS which provide examples of the successful use of InterSystems technology at VA.
  • To illustrate how InterSystems can serve healthcare data integration needs, the InterSystems and VA teams are presenting at the InterSystems Innovation Showcase at booth #942 at HIMSS.

Penumbra and Veterans Health Administration to Expand Access to Rehabilitative Care using Virtual Reality

Retrieved on: 
Tuesday, April 4, 2023
Cognition, VHA, Veterans Health Administration, Rehabilitation, Veteran, VR, REAL, Patient, Y, Virtual reality, Collaboration, NYSE, Pharmaceutical industry, Medical device, Health care, Learning

(NYSE: PEN), a global healthcare company focused on innovative therapies, today announced that it will collaborate with the Veterans Health Administration (VHA) Office of Healthcare Innovation and Learning (OHIL) to test, co-develop and implement rehabilitative health care solutions through virtual reality (VR).

Key Points: 
  • (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced that it will collaborate with the Veterans Health Administration (VHA) Office of Healthcare Innovation and Learning (OHIL) to test, co-develop and implement rehabilitative health care solutions through virtual reality (VR).
  • REAL y-Series is the only hands-free, non-tethered, multi-disciplinary VR rehabilitation platform to address high acuity to high functioning patients.
  • These solutions will largely be used for veteran neurorehabilitation and chronic condition management.
  • The REAL y-Series is currently being used in clinics and hospitals across the country to address physical rehabilitation, core and balance, cognition, functional uses, and activities of daily living.

U.S. Veterans' Health Administration (VHA) Provides Coverage of LEQEMBI (lecanemab-Irmb) Two Months After LEQEMBI's FDA Accelerated Approval for Veterans Living with Early Stages of Alzheimer's Disease

Retrieved on: 
Tuesday, March 14, 2023
The New England Journal of Medicine, Tradition, Brain, Veteran, Pathology, Co-promotion, Priority review, VHA, Lecanemab, Patient, Clarity, FDA, Clinical trial, PDUFA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, AD, Plaque, Immunoglobulin G, Pharmaceutical industry, Alzheimer's disease, Biogen, Disease, Eisai

The VHA's careful consideration and timely action to make LEQEMBI available approximately two months after the FDA approved LEQEMBI under the accelerated approval pathway shows its continued commitment to veterans living with AD.

Key Points: 
  • The VHA's careful consideration and timely action to make LEQEMBI available approximately two months after the FDA approved LEQEMBI under the accelerated approval pathway shows its continued commitment to veterans living with AD.
  • If approved under the traditional pathway, the FDA will update the label for LEQEMBI, which will include new data that has been evaluated by the FDA.
  • The FDA has determined that the results of Clarity AD will serve as the confirmatory study to verify the clinical benefit of LEQEMBI.
  • On the same day that LEQEMBI received its Accelerated approval, Eisai submitted the supplemental Biologics License Application (sBLA) to the FDA for approval under the Traditional pathway.

Endonovo Announces Distribution Agreement with Academy Medical

Retrieved on: 
Monday, March 6, 2023
VHA, SDVOSB, PEMF, Edema, Growth, Veterans Health Administration, Pain, British, Therapy, Quality of life, Health, United States Department of Defense, IDIQ, Agreement, Veteran, Partnership, OTCQB, Department of Defense Medical Examination Review Board, Department of Defence, FDA, Weisberg, Government Affairs Institute, Health insurance, Birth control, Pharmaceutical industry, Defense

Los Angeles, CA, March 06, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced the signing of a Service-Disabled Veteran-Owned Small Business (SDVOSB) Government Reseller Agreement (Agreement or Contract) with Academy Medical, Inc. of West Palm Beach, FL to distribute SofPulse® medical devices to ensure its availability to the Veterans Health Administration (VHA) and Department of Defense (DoD) contracts.

Key Points: 
  • The new Contract allows Academy Medical and Endonovo to team up and bring top-notch medical and surgical supplies, as well as telehealth solutions, to our military and veterans.
  • Additionally, this Agreement allows Academy Medical to provide its expertise in the procurement process of medical and surgical supplies to enhance access to the federal medical marketplace and the distribution of SofPulse®.
  • "Academy Medical is proud to partner with Endonovo’s SofPulse® and bring our expertise in the federal procurement process to this exciting partnership," said John Campbell, Vice President/Government Affairs from Academy Medical.
  • It also has the potential to drive growth and expansion for both Academy Medical and Endonovo as they work together to provide better medical solutions to veterans.

Noridian teams up with Verve to help Veterans nationwide

Retrieved on: 
Wednesday, February 22, 2023
WOSB, Organization, Mental, Partnership, SSG, Veterans Health Administration, Verve, United States Army Infantry School, United States Department of Veterans Affairs, Federation, Suicide, Army, VHA, SDVOSB, Nursing, Veteran, Noridian Mutual Insurance Company

Noridian and Verve are assisting grantees and Veterans Health Administration (VHA) staff with implementation activities of the Staff Sergeant Parker Fox Suicide Prevention Grant Program (SSG Fox SPGP).

Key Points: 
  • Noridian and Verve are assisting grantees and Veterans Health Administration (VHA) staff with implementation activities of the Staff Sergeant Parker Fox Suicide Prevention Grant Program (SSG Fox SPGP).
  • Noridian and Verve are developing educational and training materials on topics that help these organizations reach eligible recipients.
  • We are honored to support the VA on the SSG Fox Suicide Prevention Grantee Program with the partnership of Noridian.
  • To learn more about Noridian and its solutions for federal, state, and commercial health care programs, visit Noridian (noridiansolutions.com) .